Onno Holleboom
Onno Holleboom
Internist-endocrinoloog & vasculaire geneeskunde, Academisch Medisch Centrum, Universiteit van
Geverifieerd e-mailadres voor amc.uva.nl
Geciteerd door
Geciteerd door
Genetic variant of the scavenger receptor BI in humans
M Vergeer, SJA Korporaal, R Franssen, I Meurs, R Out, GK Hovingh, ...
New England Journal of Medicine 364 (2), 136-145, 2011
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
M Vergeer, AG Holleboom, JJP Kastelein, JA Kuivenhoven
Journal of lipid research 51 (8), 2058-2073, 2010
Compromised LCAT function is associated with increased atherosclerosis
GK Hovingh, BA Hutten, AG Holleboom, W Petersen, P Rol, A Stalenhoef, ...
Circulation 112 (6), 879-884, 2005
TNFα induces ABCA1 through NF-κB in macrophages and in phagocytes ingesting apoptotic cells
MC Gerbod-Giannone, Y Li, A Holleboom, S Han, LC Hsu, I Tabas, ...
Proceedings of the National Academy of Sciences 103 (9), 3112-3117, 2006
Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism
R Karuna, R Park, A Othman, AG Holleboom, MM Motazacker, I Sutter, ...
Atherosclerosis 219 (2), 855-863, 2011
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
J Aron-Wisnewsky, C Vigliotti, J Witjes, P Le, AG Holleboom, J Verheij, ...
Nature Reviews Gastroenterology & Hepatology 17 (5), 279-297, 2020
Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man
AG Holleboom, H Karlsson, RS Lin, TM Beres, JA Sierts, DS Herman, ...
Cell metabolism 14 (6), 811-818, 2011
Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats
NY Yoon, HR Kim, HY Chung, JS Choi
Archives of pharmacal research 31 (12), 1564-1571, 2008
Plasma levels of lecithin: cholesterol acyltransferase and risk offuture coronary artery disease in apparently healthy men and women: aprospective case-control analysis nested …
AG Holleboom, JA Kuivenhoven, M Vergeer, GK Hovingh, JN van Miert, ...
Journal of lipid research 51 (2), 416-421, 2010
The value of HDL genetics
AG Holleboom, M Vergeer, GK Hovingh, JJP Kastelein, JA Kuivenhoven
Current opinion in lipidology 19 (4), 385-394, 2008
ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden
AE Bochem, DF van Wijk, AG Holleboom, R Duivenvoorden, ...
European heart journal 34 (4), 286-291, 2013
CCDC115 deficiency causes a disorder of Golgi homeostasis with abnormal protein glycosylation
JC Jansen, S Cirak, M Van Scherpenzeel, S Timal, J Reunert, S Rust, ...
The American Journal of Human Genetics 98 (2), 310-321, 2016
TMEM199 deficiency is a disorder of Golgi homeostasis characterized by elevated aminotransferases, alkaline phosphatase, and cholesterol and abnormal glycosylation
JC Jansen, S Timal, M Van Scherpenzeel, H Michelakakis, D Vicogne, ...
The American Journal of Human Genetics 98 (2), 322-330, 2016
Cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging: carriers of lecithin
R Duivenvoorden, AG Holleboom, B van den Bogaard, AJ Nederveen, ...
Journal of the American College of Cardiology 58 (24), 2481-2487, 2011
Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism
R Karuna, AG Holleboom, MM Motazacker, JA Kuivenhoven, ...
Atherosclerosis 214 (2), 448-455, 2011
Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol
C Candini, AW Schimmel, J Peter, AE Bochem, AG Holleboom, M Vergeer, ...
Atherosclerosis 213 (2), 492-498, 2010
Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize …
RB Hildebrand, B Lammers, I Meurs, SJA Korporaal, W De Haan, Y Zhao, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (7), 1439-1445, 2010
High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C
AE Bochem, AG Holleboom, JA Romijn, M Hoekstra, GM Dallinga-Thie, ...
Journal of lipid research 54 (6), 1698-1704, 2013
Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders
G Daniil, AAP Phedonos, AG Holleboom, MM Motazacker, L Argyri, ...
Clinica chimica acta 412 (13-14), 1213-1220, 2011
High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in the Netherlands: Identification and characterization of eight novel mutations
AG Holleboom, JA Kuivenhoven, F Peelman, AW Schimmel, J Peter, ...
Human mutation 32 (11), 1290-1298, 2011
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20